Skip to content
Screener

CONMED CNMD Q3 2025 earnings

Reported November 5, 2025 · After market close

Revenue$337.9MMiss by $29.0M
EPS$1.08Beat by $0.03
Revenue estimate$366.9M
EPS estimate$1.05

Next report

Nov 4, 2026 (in 2 months)
Revenue estimate$336.3M
EPS estimate$1.00

Financials

Q3 2025

Income statement

See full
Revenue$337.9M+6.7%
Gross profit$166.1M-7.2%
Operating income$11.9M-81.9%
Net income$2.9M-94.2%
EPS (diluted)$0.09-94.3%

Balance sheet

See full
Cash & equivalents$38.9M+1.2%
Total debt$855.9M-9.3%
Total equity$1.0B+8.1%
Total assets$2.3B+0.3%

Cash flow

See full
Operating cash flow$53.7M+4.8%
CapEx$5.2M+51.7%
Free cash flow$48.5M+1.5%

Valuation & ratios

Valuation

as of 09/30/25
See full
Market cap$1.46B-34.3%
Enterprise value$2.27B-27.2%
P/E22.7×+5.9×
P/S1.1×-0.6×

Profitability

See full
Gross margin54.2%-1.4pp
Operating margin8.8%-6.6pp
Net margin4.8%-5.5pp
FCF margin11.1%-1.8pp

Returns & leverage

See full
Return on equity6.6%-8.6pp
Debt / equity0.8×-0.2×
Current ratio2.1×-0.2×

Segments

By geography

See full
Europe, Middle East & Africa$58.7M+5.7%
Asia Pacific$53.8M+9.4%
Americas (excluding the United States)$31.4M+9.1%

By product

See full
General Surgery$199.7M+7.3%
Orthopedic Surgery$138.2M+5.9%

FAQ

When did CONMED report Q3 2025 earnings?
CONMED (CNMD) reported Q3 2025 earnings on November 5, 2025 after market close.
What were CONMED's Q3 2025 revenue and EPS?
CONMED reported revenue of $337.9M and eps of $1.08 for Q3 2025.
Did CONMED beat estimates in Q3 2025?
Revenue missed the consensus estimate of $366.9M by $29.0M. EPS beat the consensus estimate of $1.05 by $0.03.
How did CONMED's Q3 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 6.7% from $316.7M a year earlier and eps grew 2.9% from $1.05.
Where can I find CONMED's Q3 2025 SEC filings?
You can read the 8-K earnings release (0000816956-25-000054) and the 10-Q periodic report (0000816956-25-000056) directly on SEC EDGAR. The filing index links above go to sec.gov.